NCT05126108

Brief Summary

Recurrent nerve monitoring for thyroid and parathyroid surgery contraindicates the pharmacologically active presence of muscle relaxant agents at the time of dissection. A recent formalized expert guideline (RFE 2018) from the French Society of Anesthesia and Resuscitation, SFAR recommends administering a curare to facilitate tracheal intubation and limit laryngeal trauma . This study aims to determine if the level of neuromuscular recovery is consistent with monitoring the recurrent nerve after the use of rocuronium for intubation. Primary endpoint: Achievement of quality intraoperative laryngeal recurrent nerve monitoring.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
50

participants targeted

Target at P25-P50 for all trials

Timeline
Completed

Started Jan 2022

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

November 8, 2021

Completed
10 days until next milestone

First Posted

Study publicly available on registry

November 18, 2021

Completed
2 months until next milestone

Study Start

First participant enrolled

January 6, 2022

Completed
5 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 30, 2022

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

May 30, 2022

Completed
Last Updated

September 12, 2025

Status Verified

September 1, 2025

Enrollment Period

5 months

First QC Date

November 8, 2021

Last Update Submit

September 5, 2025

Conditions

Keywords

Thyroid and parathyroid surgeryRecurrent nerves monitoringRocuronium

Outcome Measures

Primary Outcomes (1)

  • Quality intraoperative monitoring of the recurrent laryngeal nerve

    To assess the decurarization kinetics of rocuronium: to determine if the level of neuromuscular recovery is compatible with monitoring of the recurrent nerve after the use of rocuronium for intubation

    During surgery

Secondary Outcomes (3)

  • Copenhagen score

    During surgery

  • Arterial pressions

    During surgery

  • Cardiac frequency

    During surgery

Interventions

Thyroid and parathyroid surgery

Recurrent nerves monitoring

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Major, non-morbidly obese patients (BMI\<35) requiring general anesthesia with intubation with a Nerve Integrity Monitor (NIM) tube for thyroid and parathyroid surgery.

You may qualify if:

  • Adult subjects requiring general anesthesia for cephalic surgery (thyroid and parathyroid) with an NIM-type intubation tube.
  • Subject informed of the study and not having opposed it

You may not qualify if:

  • Allergy to any of the products used
  • Morbidly obese subjects (BMI\> 35)
  • Pregnancy
  • Predictive criteria for difficult intubation in pre-anesthetic consultation
  • Subjects under tutorship or curatorship
  • Subjects not affiliated to social security

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Surgical anesthesia service - Cochin Hospital

Paris, IDF, 75014, France

Location

Related Publications (1)

  • Marquet Y, Philippe A, Toussaint S, Abdallah SB, Morel-Fatio E, Baillard C. Rocuronium with sugammadex as a rescue reversal agent to solve conflicting recommendations for thyroid or parathyroid surgery. A prospective study. Anaesth Crit Care Pain Med. 2023 Aug;42(4):101214. doi: 10.1016/j.accpm.2023.101214. Epub 2023 Mar 6.

    PMID: 36889437BACKGROUND

MeSH Terms

Conditions

Thyroid Diseases

Interventions

Thyroid (USP)

Condition Hierarchy (Ancestors)

Endocrine System Diseases

Intervention Hierarchy (Ancestors)

Thyroid HormonesHormonesHormones, Hormone Substitutes, and Hormone Antagonists

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

November 8, 2021

First Posted

November 18, 2021

Study Start

January 6, 2022

Primary Completion

May 30, 2022

Study Completion

May 30, 2022

Last Updated

September 12, 2025

Record last verified: 2025-09

Data Sharing

IPD Sharing
Will not share

Locations